MedTrace Logo

Genetics of Hyperuricemia Therapy in Hmong

NCT02371421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-07-15

No results posted yet for this study

Summary

To pursue this objective, we will be measuring uric acid at baseline and post 14 days of twice daily allopurinol therapy in 30 Hmong participants with documented gout or hyperuricemia and known genotype for key renal transporters of uric acid.

Conditions

  • Hyperuricemia, Gout

Interventions

DRUG

Allopurinol

Sponsors & Collaborators

Principal Investigators

  • Robert J Straka, PharmD · University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02371421 on ClinicalTrials.gov